N/A N=81 PatiEnt Neuropsychological outcomeS After laseR Ablation
Cognitive Change
Primary: Site-determined Cognitive Changes Per Domain — 49; 50.7; 32.9; 35.3 Score
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=10 Transcranial Focused Ultrasound (tFUS) Modulation of Reward Network
Healthy
Primary: Resting State Functional Connectivity — 0.069; 0.160 z value
N/A N=30 Transradial-Band Pilot Study
Radial Artery Incision Site Closure
Primary: Percentage of Participants With Bleeding — 0; 1 Participants
N/A N=60 A Multidomain Intervention Program for Older People With Dementia
Dementia · Alzheimer Disease · Dementia, Mixed
Primary: Adherence — 85.4 percentage of Adherence
Phase 3 N=286 Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)
Hepatitis C Virus (HCV)
Primary: Percentage of Participants Achieving Sustained Virologic Response 12 Weeks Post-treatment (SVR12) in the Intention-to-Treat (ITT) Population — 96.2 percentage of…
N/A N=18 Clinical Decision Support for Patient Migraine Management
Migraine
Primary: Adherence to Acute Migraine Management Strategies: Treat Early — 0; 2 Participants
Phase 2 N=100 Practical Anemia Bundle for SusTained Blood Recovery
Anemia · Critical Illness
Primary: Hemoglobin Concentrations — 11.5; 12.2 g/dL — p=0.02
Phase 2 N=35 AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)
NSCLC Stage IV
Primary: Objective Response Rate (ORR) — 6 Participants
Phase 3 N=1,402 A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)
Melanoma
Primary: Recurrence-Free Survival (RFS) — NA; NA Months
Early Phase 1 N=36 Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
Keratoconus · Dry Eye · Allergy
Primary: Determine the Effect of Dexamethasone Intracanalicular Insert on Patients With Keratoconus Who Also Have Allergies — 1.67; 2 papillary grade
N/A N=132 Online Treatment of Cognitive Impairment and Insomnia in Cancer Survivors
Cancer · Insomnia · Cognitive Impairment
Primary: The Functional Assessment of Cancer Therapy - Cognitive Function (FACT-Cog) Version 3 — 39.39; 38.79; 48.28; 44.71 score on a scale
Phase 1 N=55 Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Acute Myelogenous Leukemia · Acute Lymphocytic Leukemia · Myelodysplastic Syndromes
Primary: Number of Participants With Graft Failure (Pilot Study Only) — 0 Participants
Phase 2 N=35 Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression
Major Depression
Primary: Hamilton Depression Rating Scale (HAM-D) Effect Seven Days After Dosing (D7) — 16.92; 9.72 score on a scale
N/A N=53 Repeatability and Reproducibility of Oxygen Reserve Index (ORi)
Healthy
Primary: Repeatability of Masimo Rainbow Sensors — 0.05 Mean Absolute Error (Unitless)
N/A N=31 LRTI vs Internal Brace for CMC OA
Thumb Carpometacarpal Osteoarthritis
Primary: Postoperative Follow-Up Retention Rate — 17; 13; 0; 2 thumbs